Here is an informative new tool via @dukeU@DEL_Duke for teachers and students to calculate their risk of infection with SARS-CoV-2 over the course of a semester, via aerosol spread. …re-modeler-data-devils.cloud.duke.edu 1/
Though initially developed for use on college campuses, the calculator can also be used by K-12 schools to inform decisions on school re-openings and assess the effectiveness of different control measures for COVID19 in settings like classrooms, cafeterias, and gyms. 2/
Many caveats apply to using this tool for assessing faculty and student risk of COVID-19 in the classroom, but it is still informative. Write up here: nicholas.duke.edu/news/online-to… 3/
I missed this when it came out. Ouch. “Cleansing Yale of its Republicans is necessary to live up to Yale’s mission statement to educate future leaders through the “free exchange of ideas in an ethical, interdependent, and diverse community.” yaledailynews.com/blog/2018/04/1…
I missed this one too. “What more objective account of the world can there possibly be than the one constructed from your (my, in this case) personal experience?” columbiaspectator.com/opinion/2015/0… via @homoludio
Yale does not represent political diversity of USA.
"After Daniel Elder, a prizewinning composer posted a statement on Instagram condemning arson in Nashville, where BLM protesters had set the courthouse on fire after the killing of Floyd, he discovered that his publisher would not print his music and choirs would not sing it."
"The writer Chimamanda Ngozi Adichie recently described how two younger writers she had befriended attacked her on social media, partly, she wrote, because they are 'seeking attention and publicity to benefit themselves.'"
"Once it becomes clear that attention and praise can be garnered from organizing an attack on someone’s reputation, plenty of people discover that they have an interest in doing so."
Here is an announcement from a few days ago: Ivermectin to be investigated as a possible treatment for COVID-19 in Oxford’s PRINCIPLE trial. This large well conducted trial will shed light on this topic. ox.ac.uk/news/2021-06-2…
“With known antiviral properties, ivermectin has been shown to reduce SARS-CoV-2 replication in laboratory studies. Small pilot studies show that early administration with ivermectin can reduce viral load and the duration of symptoms in some patients with mild COVID-19.”
“Even though ivermectin is used routinely in some countries to treat COVID-19, there is little evidence from large-scale randomised controlled trials to demonstrate that it can speed up recovery from the illness or reduce hospital admission.”